Expand RAPP Menu
RAPP MENU

RAPP Stock Posts


Unusual Option Volume

RAPP Rapport Therapeutics22.59-5.44 (-19.4%)

Rapport Therapeutics trades 2,513 contracts. News: Rapport Announces Pricing of Public Offering of Common Stock
Unusual Option Volume

RAPP Rapport Therapeutics27.89-3.58 (-11.4%)

Rapport Therapeutics trades 2,286 contracts. News: Rapport Announces Proposed Public Offering of Common Stock
RAPP #RapportTherapeutics stock declines -1.5% in after hours trading. See the latest news.

After Hours Decliner

RAPP Rapport Therapeutics31.47+17.11+119.2%

After Hours:31.00-0.47 (-1.5%)

Rapport Announces Proposed Public Offering of Common Stock

Globe NewswireMon, 8-Sep 4:05 PM

Unusual Option Volume

RAPP Rapport Therapeutics34.48+20.12 (+140.1%)

Rapport Therapeutics trades 2,740 contracts. The company has the following event: Rapport Therapeutics Conference Call and Webcast on RAP-219 Phase 2a Clinical Trial Results on Sep 8, 2025. News: Rapport Announces Positive Topline Results from Phase 2a Clinical Trial of RAP-219 in Patients with Focal Onset Seizures
RAPP #RapportTherapeutics stock increases 28.1% after hours.

After Hours Gainer

RAPP Rapport Therapeutics14.36-0.99-6.5%

After Hours:18.40+4.04 (+28.1%)

Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025

Globe NewswireFri, 5-Sep 4:05 PM

RAPP #RapportTherapeutics stock increases 21.7% after hours.

After Hours Gainer

RAPP Rapport Therapeutics14.36-0.99-6.5%

After Hours:17.48+3.12 (+21.7%)

Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025

Globe NewswireFri, 5-Sep 4:05 PM

Market Data Delayed 15 Minutes